The James Madison Institute
Home
About Us
Issues
Publications
Events
Press Room
Contribute
Sitemap
Contact Us

Want to know how fast Florida's state government spends your money?

Learn More

10/05/2004 - What's Wrong with Importing Prescription Drugs from Canada?

October 5, 2004

WORDS FLY AT JMI'S DEBATE ON PRESCRIPTION DRUG REIMPORTATION

Sally Pipes, a Canadian residing in the United States and president of the conservative Pacific Research Institute, faced off against Jeff Johnson, associate state director for advocacy for the Florida AARP, at JMI's October Luncheon Forum Debate, "What's Wrong with Importing Prescription Drugs from Canada?" Over 50 Institute members and friends attended the debate on the pros and cons of prescription drug importation.  Following the debate, President Bob McClure moderated a lively question and answer session from the audience members.  The event garnered news covered from WCTV Channel 6, Tallahassee's CBS affiliate, as well as Florida Public Radio.

Pictures from the Event

Sally Pipes, President, Pacific Research Institute

 

Jeff Johnson, Associate Director for Advocacy, Florida AARP

 

Jeff Johnson, Sally Pipes, and JMI President Bob McClure

 

Sally Pipes speaks with a JMI debate attendee

 

Pictured left to right: Charles Milsted, Florida AARP, Jeff Johnson, and Mark Busse, Deputy Policy Director, Office of Policy and Budget, Office of Governor Jeb Bush

 

Full Text of "10/05/2004 - What's Wrong with Importing Prescription Drugs from Canada?" (PDF, 219 KB)
You must have Adobe Acrobat installed to view this document.

Event Archive



Page Tools
Printer-Friendly
Send To A Friend
Your Account
Create Your Account
Sign In To Your Account
MEMBERSHIP

Advance the cause of liberty with your tax-deductible membership to The James Madison Institute today.

NEWSLETTER

Stay ahead of the curve with a free subscription to our weekly e-newsletter, Madison Policy Digest. You'll get all of the latest Institute updates, along with a summary of Florida's top policy headlines from a free-market point of view.